CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/27/2026
Back to search
Official data from USPTO
NEUROGYN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/27/2026
Trademark type
Combined
Nice classes
10, 41, 44
Filing date
08/01/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
CH
Examiner
REINHART, MEGHAN M
Law office
L80
Current location
Historical data usage
Mark description
The mark consists of the wording "NEUROGYN" in lowercase lettering to the right of a design comprised of incomplete circle with the top right portion of the circle design being curved inward and with a small circle appearing at the top right of the incomplete circle.
Holders and representatives
Holders
NeuroGyn AG
P. P. (pessoa física)
Representatives
Andrew D. Dorisio Dickinson Wright PLLC
Technical classification
Nice Classes
Class 10Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Implant materials for use in surgeryimplants made of artificial materials; neuroprosthesesneurological pacemakers for modulation and stimulation of nerves in the pelvic area; medical instruments and apparatuselectrodesmodulation and stimulation apparatus for neurostimulation and neuromodulation; medical monitoring devices for neurostimulation and neuromodulation; surgical instrumentsin particular for implant purposes; medical implants comprised of artificialnon-living materials for use in the pelvic area and for stimulating nerves in the pelvic area and pelvic floor area; medical apparatus for modulation and stimulation of nerves; electrically active medical implants comprised of artificial materials for neurological disease therapy and rehabilitation; implantable medical probes for pacemakers; medical electrodes for heart pacemakers; electrodes for medical use; medical leads for the application and administration of electric signals to nerves and nerve tissue for pacemakers; implantable cardiac stimulators consisting primarily of artificial materials; medical electrodes to be implanted on nerves
Class 41
Organisation of medical courses for educational and certification purposes in the field of performing surgical procedures; medical training; advanced training in the medical field; providing education in the field of medicine through correspondence courses; medical training and further education for doctors in the nature of providing live and on-line continuing professional education seminars in the medical field
Class 44
Medical assistance; medical services of a surgeonin particular in the fields of implantologyneurostimulation and neuromodulation; medical services of an orthopedistin particular in the fields of implantologyneurostimulation and neuromodulation; conducting medical and clinical examinations; medical servicesimplantation of electrodes for medical useof apparatus for modulation or stimulation in the human body for medical and therapeutic purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/10/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
09/30/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/21/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/31/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/20/2024
FIMP
FINAL DISPOSITION PROCESSED
12/20/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/23/2024
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
11/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/13/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/29/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2023
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/08/2023
RFRR
REFUSAL PROCESSED BY MPU
07/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/01/2023
CNRT
NON-FINAL ACTION WRITTEN
05/31/2023
DOCK
ASSIGNED TO EXAMINER
05/18/2023
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/18/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/20/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/20/2022
Continuous trademark protection
Get notified about every new filing that threatens NEUROGYN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.